Literature DB >> 20056754

Outcomes associated with serum calcium level in men with non-dialysis-dependent chronic kidney disease.

Csaba P Kovesdy1, Olga Kuchmak, Jun L Lu, Kamyar Kalantar-Zadeh.   

Abstract

BACKGROUND AND OBJECTIVES: Elevated serum calcium has been associated with increased mortality in dialysis patients, but it is unclear whether the same is true in non-dialysis-dependent (NDD) chronic kidney disease (CKD). Outcomes associated with low serum calcium are also not well-characterized. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We examined associations of baseline, time-varying, and time-averaged serum calcium with all-cause mortality in a historic prospective cohort of 1243 men with moderate and advanced NDD CKD by using Cox models.
RESULTS: The association of serum calcium with mortality varied according to the applied statistical models. Higher baseline calcium and time-averaged calcium were associated with higher mortality (multivariable adjusted hazard ratio (95% confidence interval): 1.31 (1.13, 1.53); P < 0.001 for a baseline calcium 1 mg/dl higher). However, in time-varying analyses, lower calcium levels were associated with increased mortality.
CONCLUSIONS: Higher serum calcium is associated with increased long-term mortality (as reflected by the baseline and time-averaged models), and lower serum calcium is associated with increased short-term mortality (as reflected by the time-varying models) in patients with NDD CKD. Clinical trials are warranted to determine whether maintaining normal serum calcium can improve outcomes in these patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20056754      PMCID: PMC2827568          DOI: 10.2215/CJN.06040809

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  41 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

3.  Ionized and total calcium variations induced by haemodialysis.

Authors:  C B Kancir; M Wanscher; P H Petersen
Journal:  Nephron       Date:  1988       Impact factor: 2.847

Review 4.  Cohort studies: marching forward.

Authors:  Ravi Thadhani; Marcello Tonelli
Journal:  Clin J Am Soc Nephrol       Date:  2006-08-02       Impact factor: 8.237

Review 5.  Bone and plasma calcium homeostasis.

Authors:  A M Parfitt
Journal:  Bone       Date:  1987       Impact factor: 4.398

6.  Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis.

Authors:  Geoffrey A Block; David M Spiegel; James Ehrlich; Ravindra Mehta; Jill Lindbergh; Albert Dreisbach; Paolo Raggi
Journal:  Kidney Int       Date:  2005-10       Impact factor: 10.612

7.  Phosphate regulation of vascular smooth muscle cell calcification.

Authors:  S Jono; M D McKee; C E Murry; A Shioi; Y Nishizawa; K Mori; H Morii; C M Giachelli
Journal:  Circ Res       Date:  2000-09-29       Impact factor: 17.367

8.  Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro.

Authors:  Hsueh Yang; Gabrielle Curinga; Cecilia M Giachelli
Journal:  Kidney Int       Date:  2004-12       Impact factor: 10.612

9.  Association of kidney function with mortality in patients with chronic kidney disease not yet on dialysis: a historical prospective cohort study.

Authors:  Csaba P Kovesdy; Bhairvi K Trivedi; John E Anderson
Journal:  Adv Chronic Kidney Dis       Date:  2006-04       Impact factor: 3.620

10.  Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.

Authors:  Deborah L Regidor; Csaba P Kovesdy; Rajnish Mehrotra; Mehdi Rambod; Jennie Jing; Charles J McAllister; David Van Wyck; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  J Am Soc Nephrol       Date:  2008-07-30       Impact factor: 10.121

View more
  23 in total

1.  Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients.

Authors:  Jessica E Miller; Csaba P Kovesdy; Keith C Norris; Rajnish Mehrotra; Allen R Nissenson; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2010-09-03       Impact factor: 3.754

2.  Racial Differences in Association of Serum Calcium with Mortality and Incident Cardio- and Cerebrovascular Events.

Authors:  Jun Ling Lu; Miklos Z Molnar; Jennie Z Ma; Lekha K George; Keiichi Sumida; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  J Clin Endocrinol Metab       Date:  2016-09-15       Impact factor: 5.958

3.  Prevalence and risk factors for hypercalcemia among non-dialysis patients with chronic kidney disease-mineral and bone disorder.

Authors:  Jun Jie Benjamin Seng; Ying Lin Cheryl Tan; Rou Wei Lim; Hui Ting Sarah Ng; Puay Hoon Lee; Jiunn Wong
Journal:  Int Urol Nephrol       Date:  2018-06-07       Impact factor: 2.370

Review 4.  Arterial calcification in chronic kidney disease: key roles for calcium and phosphate.

Authors:  Catherine M Shanahan; Matthew H Crouthamel; Alexander Kapustin; Cecilia M Giachelli
Journal:  Circ Res       Date:  2011-09-02       Impact factor: 17.367

5.  Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney disease.

Authors:  Lilia R Lukowsky; Miklos Z Molnar; Joshua J Zaritsky; John J Sim; Istvan Mucsi; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2011-12-29       Impact factor: 5.992

Review 6.  Fibroblast growth factor-23: what we know, what we don't know, and what we need to know.

Authors:  Csaba P Kovesdy; Leigh Darryl Quarles
Journal:  Nephrol Dial Transplant       Date:  2013-04-25       Impact factor: 5.992

Review 7.  Rationale to reduce calcium intake in adult patients with chronic kidney disease.

Authors:  Sharon M Moe
Journal:  Curr Opin Nephrol Hypertens       Date:  2018-07       Impact factor: 2.894

8.  Disorders in bone-mineral parameters and the risk of death in persons with chronic kidney disease stages 4 and 5: the PECERA study.

Authors:  Pablo Molina; Mariola D Molina; Luis M Pallardó; Javier Torralba; Verónica Escudero; Luis Álvarez; Ana Peris; Pilar Sánchez-Pérez; Miguel González-Rico; María J Puchades; José E Fernández-Nájera; Elena Giménez-Civera; Luis D'Marco; Juan J Carrero; José L Górriz
Journal:  J Nephrol       Date:  2021-01-04       Impact factor: 3.902

Review 9.  [FGF23 and the heart].

Authors:  I Ezumba; L D Quarles; C P Kovesdy
Journal:  G Ital Nefrol       Date:  2014 Nov-Dec

10.  Association of depression and antidepressant use with mortality in a large cohort of patients with nondialysis-dependent CKD.

Authors:  Rasheed A Balogun; Emaad M Abdel-Rahman; Seki A Balogun; Evan H Lott; Jun Ling Lu; Sandra M Malakauskas; Jennie Z Ma; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-16       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.